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We present a computational model to study the spatiotemporal dynamics of the epidermis
homeostasis under normal and pathological conditions. The model consists of a population
kinetics model of the central transition pathway of keratinocyte proliferation, differentiation and
loss and an agent-based model that propagates cell movements and generates the stratified
epidermis. The model recapitulates observed homeostatic cell density distribution, the epidermal
turnover time and the multilayered tissue structure. We extend the model to study the onset,
recurrence and phototherapy-induced remission of psoriasis. The model considers the psoriasis as a
parallel homeostasis of normal and psoriatic keratinocytes originated from a shared stem-cell niche
environment and predicts two homeostatic modes of the psoriasis: a disease mode and a quiescent
mode. Interconversion between the two modes can be controlled by interactions between psoriatic
stem cells and the immune system and by the normal and psoriatic stem cells competing for growth
niches. The prediction of a quiescent state potentially explains the efficacy of the multi-episode
UVB irradiation therapy and recurrence of psoriasis plaques, which can further guide designs of
therapeutics that specifically target the immune system and/or the keratinocytes.
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I. INTRODUCTION
The epidermis, the outermost layer of skin, provides the
human body a physiological barrier to the environment and
protects the body from water loss, pathogenic infection
and physical injury. The epidermis organizes into a
stratified structure of keratinocytes at several differentiated
stages [1], which constitute 95% cell population in the
epidermis [2]. Like other regenerative tissues, the epidermis
constantly renews itself to replace desquamated and apoptotic
keratinocytes, repair tissue damage and establish the
homeostasis. The renewal is orchestrated by a cascade
of cellular processes including proliferation, differentiation,
migration, apoptosis and desquamation [3–5]. A keratinocyte
transits spatially from the stratum basale to the stratum
corneum during its lifespan and meanwhile experiences
multi-stage biochemical and morphological changes. Many
endogenous and exogenous factors (e.g., Ca2+ concentration,
cytokines, UV irradiation, etc.) affect the epidermal dynamics
and the homeostasis of the epidermis by regulating one or
more cellular processes.
Mathematical and computational models have long been
useful tools to predict cellular behaviors of the epidermis
renewal under normal or pathological conditions. Previous
models for the epidermal dynamics usually adopted two
approaches. One approach includes deterministic models that
derived analytical solutions to stationary cell populations.
For example, the model by Savill [6] described proliferation
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of stem cells and transit-amplifying cells and differentiation
to post-mitotic cells, which predicted the influences of
apoptosis, cell-cycle time and transit time on cell populations.
Gandolfi et al. [7] proposed a spatiotemporal model to
investigate the evolution of epidermis, which described
cell motion by a constitutive equation. The other
approach includes agent-based models that treat individual
keratinocytes as computing entities operating under specific
physical and biological rules. Such models can simulate
the multi-layer epidermal structure organized by cell
proliferation, differentiation, death and migration, in which
nonspecific intracellular and extracellular biochemical factors
affected cell proliferation and differentiation while physical
adhesive and repulsive forces governed cell motion [8–12].
In this paper, we present a hybrid model to combine
advantages of the above two approaches. The model
uses a mean-field cell population kinetics together with an
agent-based model for cell migration. The model computes
population dynamics of the epidermal renewal without having
to compute the cell movements simultaneously, allowing
fast and analytical evaluations of modeling hypotheses and
results. The population kinetics model describes cellular
processes including cell division, differentiation, apoptosis
and desquamation. Either deterministic or stochastic
simulation can be used to generate the population dynamics
of keratinocytes. The cell migration is described by a
two-dimensional agent-based model that tracks the cell
movement driven by cell-cell interactions. Simulation of
the cell migration can be integrated with the stochastic
population dynamics to visualize the tissue stratification and
establishment of homeostasis. A properly parameterized
model reproduces experimentally-observed epidermis growth,
differentiation and desquamation dynamics, homeostatic
density distribution over different types of keratinocytes and
the epidermis turnover times of different cell compartments.
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FIG. 1. The central transition pathway of the epidermis renewal. The model describes proliferating and nonproliferating
keratinocytes. Stem cells and transit amplifying cells proliferate by self-renewal and by symmetric division and asymmetric
division. The transit-amplifying cells differentiate into the growth-arrested cells in the nonproliferative compartment, which
in turn differentiate into keratinocytes of later stages, including spinous cells, granular cells and corneocytes. Nucleated cells
undergo apoptosis and corneocytes desquamate from the stratum corneum. All cellular processes are parameterized by rate
constants labeled on transitions.
To investigate an important pathological condition of
the skin, we study the onset and recurrence of psoriasis
plaques and their recovery under the phototherapy by
UVB irradiation. The psoriasis is a complex epidermal
disorder characterized by keratinocyte hyperproliferation and
abnormal differentiation due to intricate interactions with the
immune system. The disease affects 2-4% of the general
population and currently has no cure [13, 14]. Specifically,
we hypothesize a novel mechanism of stem cell-immune
system interaction and predict the chronic disorder as a
bimodal switch between a disease phenotypic and a quiescent
(seemingly-normal) state. The model hypothesizes a parallel
epidermal homeostasis simultaneously maintained by the
normal and the psoriatic keratinocytes. The psoriatic
homeostasis is caused by permanent perturbations in cell
division, apoptosis and differentiation, derived from defective
stem cells and their interactions with a weakened immune
system. For treatment, the model predicts that to achieve
a controlled remission the effective treatment of UVB
irradiation must reduce the high-density psoriatic epidermis
below a threshold level by activating the apoptosis in stem
cells, potentially explaining the chronicity and recurrences
of the disorder and providing a guide to design feasible
therapeutics.
II. THE MODEL
The model consists of (1) a kinetics model, which tracks
the temporal evolution of cell population of keratinocytes
at several differentiation stages, and (2) a migration model,
which describes motion of individual cells to generate the
stratified structure of the epidermis. One can choose the
kinetic model as a standalone module to compute the
mean-field population dynamics or can integrate the two
models to visualize the renewal kinetics and stratification of
the tissue.
A. Model of cell population kinetics
Figure 1 illustrates the central transition pathway of the
epidermis renewal. The pathway considers the population
dynamics of six categories of keratinocytes stratified from
the stratum basale to the stratum corneum, including
progenitors, stem cells (SC) and transit-amplifying (TA) cells
in the proliferative compartment, and differentiated cells in
the nonproliferative compartment with growth-arrested (GA)
cells, spinous (SP) cells, granular cells (GC) and corneocytes
(CC). The above classification is primarily based on known
histological structure and physiological function of the human
epidermis [15]. Growth-arrested cells are precursors for
nonproliferating cells. Spinous cells and granular cells
are fully differentiated keratinocytes, and the nonnucleated
corneocytes represent the end-stage differentiation and
eventually desquamate. The central transition pathway
incorporates three main cellular processes: (1) proliferation
of stem cells and transit-amplifying cells, (2) differentiation
including several inter-category cell conversions, and (3) cell
loss including apoptosis of nucleated cells and desquamation
of the corneocytes.
How stem cells maintain the epidermal homeostasis
remains unresolved [16]. However, recent long-term in
vivo lineage tracing studies on mouse tail tissue by genetic
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FIG. 2. Proliferation of stem cell and TA cell. Both
stem cell and TA cell undergo three types of divisions: (i)
self-proliferation, (ii) asymmetric division and (iii) symmetric
division.
3labeling revealed remarkable details about clonal dynamics
of epidermal progenitors, suggesting the existence of either
single (stem cell alone) or two progenitors (stem cell and
committed progenitor) [17–19]. As illustrated in Fig. 2,
our model considers a slow cycling stem cell population
together with a faster proliferating committed progenitors
(or, transit-amplifying cells). A stem cell divides in one of
three modes [20–22]: (i) self-proliferation, by which a stem cell
divides into two daughter stem cells, (ii) asymmetric division,
by which a stem cell divides into a stem cell and a TA cell,
or (iii) symmetric division, by which a stem cell divides into
two TA cells. Considering a finite availability of stem cell
niches [20, 23], we assume a logistic growth of stem cells to
limit the stem cell density by a maximal growth capacity,
which ensures the system to reach a well-defined steady state
(see Ref. [24] for a more general model that guarantees a
steady state). Previous models [17, 25] required a precise
balance between stem cell self-proliferation and symmetric
division and were intolerable to arbitrary perturbations such
as population random drift caused by intrinsic stochasticity
in the three-mode stem cell division. Similarly, TA cells
also divide in one of the three modes of self-proliferation,
symmetric and asymmetric division into the GA cells [17, 26,
27]. In addition, a TA cell may resume the stem cell state and
a GA cell may resume a TA cell state by backconversions [28].
The rate of progenitor division is often characterized by
the cell-cycle time and by the subpopulation of cells that are
active to divide (also known as the “growth fraction”). Our
mean-field model does not distinguish proliferative propensity
in individual cells and therefore parameterizes cell divisions
with empirical rate constants that integrate influences of the
cell cycle and the growth fraction. Environmental changes
regulate the proliferation rate of stem cells. For example,
the need of repairing tissue damage promotes stem cell
proliferation [19, 21, 29]. Recent study of hair follicles
showed that TA cells may signal to stem cells to regulate
proliferation [30]. To incorporate this feedback mechanism,
we assume an empirical dependence of stem cell division rate
constants, γ1, k1a and k1s, on the density of TA cells and
define:
γ1
γ1,h
=
k1a
k1a,h
=
k1s
k1s,h
=
ω
1 + (ω − 1)(pta/pta,h)n , (1)
where the subscript h indicates a homeostatic rate constant
(see Table III for numerical values), and ω ≡ rx,max/rx,h is the
ratio of the maximum division rate to the homeostatic rate
and is assumed identical for all division processes. ω reflects
the maximum increase in the growth fraction and/or decrease
in the cell cycle time when stem cell proliferation accelerates.
At homeostasis of the normal epidermis, the reported growth
fraction varied from 20% to 70% [31, 32]. Study in mice
epidermis found more than 10-fold decrease in the cell cycle
time from 5-7 days to 11 hours following tissue abrasion [33],
whereas no significant change in cell cycle time was found
in psoriasis [34, 35]. The exponent n models the sensitivity
to the deviation of TA density from the homeostasis. In the
limit of a much reduced TA cell density (pta  pta,h), stem
cells divide at the maximum rate, rx,max, whereas stem cells
divide at a minimal rate when TA cells overpopulate (pta 
pta,h). The total stem cell proliferating rate at homeostasis is
set about 10−2 per day, aligned with 4-6 division events per
year [19].
The nonproliferative compartment describes a cascade of
differentiations from GA cells to corneocytes. The model also
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FIG. 3. Mechanics of cell migration. Keratinocytes
are geometrically modeled as irrotational ellipsoids with two
principal axes staying horizontal or vertical. (a) A repulsive
force is determined by an overlap between neighboring cells.
The repulsion Fr12 between cells 1 and 2 is proportional to
the overlapping area S12 approximated by the corresponding
overlap rectangle. Fr13 is determined similarly. The net
repulsion on cell 1 is a vector sum Fr1 = F
r
12 + F
r
13. (b)
The adhesive force exists between two adjacent cells. The
force Fa12 is related to the distance between cell 1 and cell 2.
The direction of Fa12 or F
r
12 acting on cell 1 is paralleled to
the line (dashed) connecting centers of cell 1 and cell 2. The
repulsive force and adhesive force between two overlapped
cells are balanced by the force generated by viscosity due
to cell motion. Cell motion is only translational without
rotation. w and h denote the width and height of a cell.
(c) Epidermis thickness, rete ridge height, and undulant
basement membrane geometrically configure the epidermis in
a 2D projection.
considers an apoptosis process for all nucleated keratinocytes.
Early studies suggested that apoptosis was only significant
for stem cells and transit-amplifying cells in the proliferative
compartment [36]. Recent experiment [37] also showed that
apoptosis was evident in the differentiated keratinocytes. The
extent of apoptosis is commonly characterized by apoptotic
4index, which is typically quantified using the TUNEL
(transferase-mediated uridine nick end labelling) assay [36].
For a cell type i, the apoptosis index equals the probability
that a cell undergoes apoptosis, defined as the ratio of
apoptosis rate fapopi to the total outflux f
out
i including rates
of apoptosis and transition to the downstream cell category:
AI =
fapopi
fouti
=
βi
βi + ki
, i = 1, ...5 , (2)
For stem cells and TA cells, k1 = k1s and k2 = k2s
are symmetric division rate constants. Experiments often
reported global apoptosis indices that did not differentiate
apoptotic activities in proliferative and non-proliferative
compartments. Apoptotic heterogeneities of cells within a
compartment is even less known. Here each cell category is
assumed an identical apoptosis index that is used to calculate
the apoptosis rate constants β′is. Governing system equations
(ODEs) are listed in Table I and computation of the model is
described in the Supplementary Material (Fig. S1).
B. Model of cell migration
The agent-based migration model describes movement
of all keratinocytes in a two-dimensional (cross-sectional)
epidermis volume. Keratinocytes once derived from stem
cells move outward from the stratum basale to the outermost
stratum corneum, to compose a stratified epidermis. The
model describes cell mechanics that propels cell movement.
An individual cell is subject to three forces: (i) a viscous
force due to cell moving in the surrounding environment; (ii)
a repulsive force due to cell-cell compression; and (iii) an
adhesive force due to interactions among adhesive molecules
on cell membranes. Considering the sluggish keratinocyte
motion (in a scale of µm/hr) in a fluidic environment with a
low Reynolds number (i.e., viscosity dominates inertia) [38],
the model neglects the acceleration due to inertia. The model
also considers keratinocytes as non-chemical tactic cells that
do not move by self-propulsion. The force balance for the ith
cell is
µ
dxi
dt
+ Fri + F
a
i = 0 , (3)
where vector xi is the cell-center coordinate, and µ is the
viscosity coefficient. The first term in Eq. (3) is the viscosity
of the epidermis. Fri and F
a
i are repulsive and adhesive forces
between neighboring cells, which are sums of forces derived
from all individual pairwise contacts,
Fri =
∑
j=O(i)
Frij , F
a
i =
∑
j=Ω(i)
Faij , (4)
where O(i) and Ω(i) denote sets of cells overlapping and
neighboring with the ith cell and Frij and F
a
ij are force vectors
produced onto cell i by interaction (repulsion or adhesion)
between cells i and j. By symmetry, Frij = −Frji and
Faij = −Faji. The model treats individual cells as rigid-body
agents and uses the extent of virtual cell overlap to determine
the repulsive force [Fig. 3(a)]. Adhesion between two cells
is a function of their spatial distance [39, 40] [Fig. 3(b)].
Computation of Frij and F
a
ij is given in the Supplementary
Material.
Previous agent-based models [9, 11, 41] treated
keratinocytes as identically-sized circles or spheres. However,
cells progressively adopt varied shapes and sizes at different
stages of differentiation. Cells in an outer layer generally have
more flattened cell body and larger surface area, compared
to cells in layers underneath. Tissue location in the body
can also influence the cell geometry. For example, compared
to the mean basal cell diameter of 6-8 µm at the forearm
and hand [42], at unexposed sites in the adult tissue [3], the
average cell diameter in the proliferative compartment is
about 10 µm whereas the average differentiated cell diameter
is about 16 µm. For simplicity, we use ellipsoids to model
geometric heterogeneity in cell morphology and size. Cell
types are distinguished by the mean major-to-minor axis
ratio and the mean nominal size.
The basement membrane of the epidermis is undulant
with rete ridges extending downward between the dermal
papillae [Fig. 3(c)]. In adult human epidermis, the average
rete ridge height is about 40 µm in the adult tissue, and
about six rete ridges along 1 mm cross-sectional tissue length
were observed [47], which changes with age. The basement
membrane is modeled by periodically-repeating Gaussian
functions (see the Supplementary Material). Parameters of
cell sizes and epidermis thickness are listed in Table II.
III. RESULTS
The model recapitulates two important measures of the
epidermis homeostasis: cell counts in different layers and the
epidermal turnover times in different compartments.
A. Homeostatic cell density distribution
The mean homeostatic cell densities can be analytically
calculated from the ordinary differential equations in Table I
as follows (see Table III for definitions of parameters).
psc = p
max
sc
1− 1
γ1
k1s + β1 − k−1(k1a + 2k1s)
k−1 + k2s + β2 − γ2 − k−2(k2a+2k2s)k−2+k3+β3
 ,
(5)
pta =
k1a + 2k1s
k−1 + k2s + β2 − γ2 − k−2(k2a+2k2s)k−2+k3+β3
psc , (6)
pga =
k2a + 2k2s
k−2 + k3 + β3
pta, (7)
psp =
k3
k4 + β4
pga , (8)
pgc =
k4
k5 + β5
psp, (9)
pcc =
k5
α
pgc , (10)
and the total cell density is given as
ptot = psc + pta + pga + psp + pgc + pcc . (11)
The density of each cell category is proportional to the
epidermis capacity of stem cells, pmaxsc and the ratio between
densities of any pair of cell types is a constant. Therefore,
5TABLE I. Kinetic equations for the epidermal renewal and homeostasis
Cell type Rate equation
Stem cell (SC) dpsc/dt = [γ1(1− psc/pmaxsc )− k1s − β1]psc + k−1pta
Transit-amplifying (TA) cell dpta/dt = (γ2 − k2s − β2 − k−1)pta + (k1a + 2k1s)psc + k−2pga
Growth-arrested (GA) cell dpga/dt = (k2a + 2k2s)pta − (k−2 + k3 + β3)pga
Spinous cell (SP) dpsp/dt = k3pga − (k4 + β4)psp
Granular cell (GC) dpgc/dt = k4psp − (k5 + β5)pgc
Corneocytes (CC) dpcc/dt = k5pgc − αpcc
psc, pta, pga, psp, pgc, and pcc are cell densities.
observed cell density distribution can be used to identify
kinetic parameters. The homeostatic TA-cell density is
pta,h =
k1a,h + 2k1s,h
k−1 + k2s + β2 − γ2 − k−2(k2a+2k2s)k−2+k3+β3
psc,h (12)
Kinetic parameters must satisfy two necessary conditions to
establish a physiologically proper steady state:
γ1,h > β1+k1s,h− k−1(k1a,h + 2k1s,h)
k−1 + k2s + β2 − γ2 − k−2(k2a+2k2s)k−2+k3+β3
(13)
k−1 + k2s + β2 > γ2 +
k−2(k2a + 2k2s)
k−2 + k3 + β3
. (14)
Given small backconversion rate (k−1 and k−2 assumed at
10−6 per day, 3-5 orders of magnitude smaller than the stem
cell and TA cell proliferating rate constants, Table III), the
above conditions simplify to
γ1,h > k1s,h + β1, and γ2 < k2s + β2 , (15)
The first condition ensures the establishment of a viable stem
cell population, whereas the second condition prevents an
unchecked growth of the epidermis because the proliferation
of TA cells is not limited by a maximum capacity in the
model. These conditions extend previous treatment that
required a precise balance between self-proliferation and
symmetric division in progenitor cells when apoptosis was
neglected [17, 25]. Apoptosis is a rare event compared
to progenitor self-proliferation and symmetric division (e.g.,
β1  γ1,h, and  k1s,h; see Table III) and plays a secondary
role in regulating the epidermal homeostasis.
A recent study of progenitors in mice interfollicular
epidermis by Mascre´ et al. [19] suggested that in homeostasis
TABLE II. Parameters for cell size and the undulant
rete ridge
Cell type w (µm) × h (µm) Reference
Stem cell 10× 15 [3, 42]
Transit-amplifying cell 10× 15 [3, 42]
Growth-arrested cell 12× 10 [3, 42]
Spinous cell 12× 8 [3, 42]
Granular cell 22.5× 4 [3, 42]
Cornified cell 35× 1 [43–46]
Rete ridge parameters (see Supplementary Materials):
A =63 µm, B =23 µm, σs =70 µm [47]
stem cells proliferate by 4-6 division events per year, 10-20
times slower than proliferation and differentiation (about 1.2
events per week) of committed progenitors (TA cells in our
model). This information is reflected such that k1a,h + 2k1s,h
is an order of magnitude smaller than γ2 + 2k2s. However,
considering that TA cells have a much larger population than
stem cells (pta/psc ≈ 5 [32]), rates of stem-cell asymmetric
and symmetric divisions into TA cells (k1a,h + 2k1s,h) must
be about 5-fold greater than the difference between TA-cell
self-proliferation and symmetric division, i.e., k2s + β2 − γ2
based on Eq. (6), assuming backconversion rates (k−1 and
k−2) are negligible. Therefore, the model predicts that mild
perturbations on TA-cell dynamics including proliferation and
apoptosis may have substantial effects on the homeostatic
keratinocyte population.
The model recapitulates the dynamics and the homeostatic
cell density distribution and the epidermal turnover time,
in both deterministic and stochastic simulations [Fig. 4(a)].
Starting from an initial stem-cell population, the cell density
rapidly increases to reach about 80% of the homeostatic
density in the transient phase of the first 100 days and
significantly slows down when it approaches the homeostasis.
The simulation reached the homeostasis in about 2000 days to
a total density at 101684 cells/mm2. The transient dynamics
is more than an order of magnitude slower than that in the
model by Grabe et al. [9, 48], where the authors reported
a near 2000-hour transient dynamics from an initial stem
cell population to a homeostasis. This discrepancy is caused
by a slow stem cell dynamics of 4-6 cell events per year
reported recently [19], which also agrees with early-reported
cell cycle of 100-200 hrs in a 20% growth fraction in an
animal model [49]. Therefore, the stem cell dynamics (Eq. 1)
becomes a rate-limiting step to the dynamic establishment
of a homeostasis, notably when the system approaches the
homeostasis.
Figure 4(b) shows a histogram of the simulated steady-state
cell density distribution over different cell types. Stem cells,
TA cells and GA cells in stratum basale consist of 22%
total cell population, in which proliferating cells accounts for
13.2% total cell population, consistent with the experimental
data [32, 50, 51]. Studies by Bergstresser et al. [52] also
suggested that 30% of nucleated keratinocytes were in the
basal layer where stem cells occupied 10% population [32].
Spinous and granular cells are the majority, consisting of
51.3% total keratinocytes with the population of spinous cells
nearly two times that of granular cells, in agreement with
a previous prediction by Grabe et al. [9, 48]. Corneocytes
consist of 26.6% of the total cell population. Bauer et
al. [50] measured a mean nucleated keratinocytes density of
75346 cells/mm2 whereas the non-nucleated corneocytes was
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FIG. 4. Dynamic and homeostatic keratinocytes density distribution. (a) Temporal evolutions of cell population of
different types of keratinocytes by a deterministic simulation (smooth curves) and a stochastic simulation (fluctuated curves).
Deterministic simulations started with an initial stem cell density of 1000 mm−2, which corresponds to 10 cells under a skin
area of 0.01 mm−2 for the stochastic simulation. (b) The histogram of the steady-state cell density distribution. (c) Snapshots
at day 1, 35, 102, and 988 of the visualization of the two-dimensional epidermis with a thickness of 10 µm. Simulation started
with stem cells randomly located along the basement membrane (day 1). Parameter values used in simulations are listed in
Table III.
estimated to be about 18000 cells/mm2, consisting of 19.3%
total cell population [51].
Figure 4(c) shows snapshots of temporal evolution of
two-dimensional epidermal stratification from an initial group
of stem cells distributed along the basement membrane to
the homeostasis. We compute the cell population dynamics
and the cell migration within an area of 1 mm in length by
10 µm in width. The cell density is defined over a surface
area number of keratinocytes per mm2 without explicitly
considering the epidermis height. The choice of 10 µm (about
the mean cell size) is to visualize a two-dimensional single
layer of keratinocytes. The simulated tissue histology shows
that the thickness of the nucleated epidermis is about 60 µm,
aligning with observations ranging from 38 µm to 77 µm with
a mean of 60 µm in the adult tissue, with little variation
across age groups [42, 47, 50]. A movie of the epidermis
renewal process of the normal tissue is available at URL:
http://www.picb.ac.cn/stab/epidermal.html.
7B. The epidermal turnover time
Another common measure of epidermis homeostasis is
the epidermal turnover time τ . At the tissue level, τ
is interpreted as a time required for replacing the entire
epidermis with new keratinocytes. The epidermal turnover
time varies significantly with age groups, tissue locations
and cell densities. In earlier studies, τ has been reported
approximately 6-7 weeks in the volar forearm with a nucleated
cell density of 44000 mm−2 [53, 54]. Based on a more
recent count of nucleated cell density of 75346 mm−2 on
breast skin [50], Hoath and Leahy [51] suggested that τ
should be calculated as 59.3 days. Renewal of a specific
layer of keratinocytes takes a shorter turnover time. The
turnover times of the stratum basale and the differentiated
compartment were reported being about 22 and 12 days [54],
whereas the stratum corneum has a turnover time that
varies from 14 days [54, 55] to about 20 days in young
adult [56]. Following the convention [54], we calculate τ as
the ratio of total cell density to the rate of cell loss including
desquamation and apoptosis, or alternatively, the ratio of
total cell density to the rate of cell birth by stem cell and TA
cell divisions because cell birth and death rates are balanced
at homeostasis:
τ =
ptot
rgrowth
=
ptot
rloss
, (16)
where the rates of cell growth and cell loss are
rgrowth = [γ1(1− psc/pmaxsc ) + k1a + k1s]psc
+(γ2 + k2a + k2s)pta
rloss = β1psc + β2pta + β3pga + β4psp + β5pgc + αpcc .
Analytical solution to τ can be obtained by substituting
Eqs. (5)-(10) into the above equation. Apoptosis events
represent rare ramifications from the central transition
pathway in the normal epidermis renewal. Rate constant
of an apoptotic process βi (10
−4-10−5/day) is much smaller
than the differentiation and desquamation rate constants ki
and α (about 10−1/day, see Table III). We can approximate
rloss by the rate of desquamation. By also neglecting the
backconversions, we have
τ = τprolif + τdiff + τcorn , (17)
where
τprolif =
(
k2s − γ2
k1a + 2k1s
+ 1
)
1
k2a + 2k2s
(18)
τdiff =
1
k3
+
1
k4
+
1
k5
τcorn =
1
α
.
τ is the sum of contributions by sub-compartment turnover
times as keratinocytes migrate from the proliferative
compartment (τprolif) through the differentiated compartment
(τdiff) and then through the stratum corneum (τcorn). We
note that τ is independent of the stem cell self-proliferation
γ1 and the stem cell capacity p
max
sc . These two parameters
determine the steady-state stem cell density psc. Both cell
density and cell growth rate are proportional to psc, which
masks the effect of stem cell self-proliferation dynamics on the
turnover times. The turnover time of a single cell category is
the inverse of the rate constant for the transit to the next cell
category. Therefore, τ can be dominated by a rate-limiting
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FIG. 5. Illustration of stem-cell niche environments in
the psoriatic tissue. At the quiescent mode (left panel),
healthy stem cells dominate in population, residing in the
normal niche repertoire. At the psoriatic mode, psoriatic stem
cells dominate in population and the niche repertoire expands
to accommodate a larger population of psoriatic stem cells.
step in the cell growth and differentiation cascade. From
the calculation by Eq. (16) using parameters in Table III,
τ is about 52.5 days, partitioned into 7, 31.5 and 14 days
in the proliferative compartment, differentiated compartment
and the stratum cornuem, respectively, within the wide range
of reported adult-tissue measurements between 39 and 75
days [3, 53, 55].
C. Pathogenesis of psoriasis
To investigate an important epidermis disorder, we extend
the above model to study the onset and recurrence of
psoriasis and its management. Psoriasis, an immune
system-mediated chronic skin condition, is characterized
by an overproduction of keratinocytes accompanied by
inflammation [66], resembling features found in many
autoimmune diseases. Here, we focus on studying the
most prominent type of the disorder, psoriasis vulgaris, a
plaque-formed scaly silvery patch, affecting the majority of
psoriasis patients.
Current studies are inconclusive about whether psoriasis
(1) arises from genetically hyperproliferative progenitor
keratinocytes, or (2) is alternatively induced by a
faulty immune system, particularly dendritic cells and T
lymphocytes over-response to unresolved self antigens, which
in turn produces excessive cytokines (such as TNFα) to
promote keratinocyte proliferation, or (3) more likely an
intricate interplay between keratinocytes and the immune
system [66, 67].
To examine the pathogenesis of psoriasis, we emphasize an
interplay between keratinocytes overproduction and responses
by the immune system. Our fundamental hypothesis is that
a psoriatic epidermis assumes two groups of keratinocytes:
normal and psoriatic, maintaining a parallel homeostasis. The
8TABLE III. Model parameters
Cell population kinetics model
Parameter description Notation (unit) Value Source
SC growth capacity pmaxsc (mm
−2) 4.50e3 Assumed
Nominal SC self-proliferation rate constant γ1,h (d
−1) 3.30e-3 Estimated
Nominal symmetric SC division rate constant k1s,h (d
−1) 1.64e-3 [17, 19]
Nominal asymmetric SC division rate constant k1a,h (d
−1) 1.31e-2 [17, 19]
TA cell self-proliferation rate constant γ2 (d
−1) 1.40e-2 [32, 50–52]
TA cell symmetric division rate constant k2s (d
−1) 1.73e-2 [32, 50–52]
TA cell asymmetric division rate constant k2a (d
−1) 1.38e-1 [32, 50–52]
GA-to-SP cell differentiation rate constant k3 (d
−1) 2.16e-1 [50, 51]
SP-to-GC cell transit rate constant† k4 (d−1) 5.56e-2 [50, 51]
GC-to-CC cell transit rate constant† k5 (d−1) 1.11e-1 [50, 51]
CC cell desquamation rate constant α (d−1) 7.14e-2 [50, 51, 55]
Backconversion rate constant (TA to SC) k−1 (d−1) 1.00e-6 Assumed
Backconversion rate constant (GA to TA) k−2 (d−1) 1.00e-6 Assumed
Maximum fold increase of SC proliferation rate ω 100 [31–33]
Steepness SC proliferation rate regulation by TA cell population n 3 Assumed
Normal epidermal apoptosis index AIh 0.12% [36, 50, 51]
Psoriatic epidermal apoptosis index AId 0.035% [36, 50, 51]
Fold change of psoriatic SC proliferation ρsc 4 [57]
Fold change of psoriatic TA proliferation ρta 4 [57]
Fold change of psoriatic cell transit rate † ρtr 5 [58, 59]
Fold change of psoriatic corneocyte desquamation ρde 4 [55]
Fold change of psoriatic SC growth capacity λ 3.5 [60, 61]
Maximum immune killing rate Kp (mm
−2d−1) 6 Assumed
Immune half-activation psoriatic SC density Ka (mm
−2) 380 Assumed
Cell migration model
Parameter description Notation (unit) Value Source
Viscosity coefficient µ (nN·s·µm−1) 250 [39]
Elasticity constant k (nN·µm−2) 0.04 Estimated
Adhesion factor of proliferating cells, SC and TA σp (nN) 50 [39, 40]
Adhesion factor of GA and SP and GC σd (nN) 5 [39, 40, 62]
Adhesion factor of CC σc (nN) 0.5 [39, 40, 62]
Mean cell radius r (µm) 5 Estimated
Time constant of rete ridge remodeling τ (d) 1000 [63–65]
Maximum rete ridges height of psoriatic epidermis Ymax (µm) 126 Assumed
Minimal rete ridges height of normal epidermis Ymin (µm) 40 [47]
†In the psoriasis model, due to lack of the granular layer k4 is the rate constant for SP to CC transition,
k5 is unused, and ρtr is the fold change in k3 and k4.
psoriatic keratinocytes are derived from a hyperproliferative
stem cell population co-residing with the normal stem cells
at the basement membrane, which compete for limited stem
cell niches ((see Fig. 5 for illustration). This hypothesis can
be justified by the existence of intrinsically hyperproliferative
stem cells or stem cells that are more responsive to growth
stimulants originated from an activated immune system. We
modify the above model to describe the competition for niches
between the normal and psoriatic stem cells. Dynamics of
psoriatic TA and nonproliferative cells are governed by rate
equations as in Table I for the normal keratinocytes, however,
with different parameter values to generate known phenotypes
in psoriatic plaques, with an exception of granular cells that
are missing in psoriasis. The dynamics of psoriatic stem
cells in our model is similar to the model of spruce budworm
outbreak by Ludwig et al. [68], which models a single-species
population growth under predation.
dpsc
dt
=
[
γ1
(
1− psc + p˜sc/λ
pmaxsc
)
− k1s − β1
]
psc + k−1pta
(19)
9TABLE IV. Cell density distribution (mm−2) and turnover times (day)∗
Healthy tissue Psoriasis† Non-symptom†
SC 2268 362+6459 2232+124
TA 11219 77+32098 10715+618
GA 8964 61+20536 8562+395
SP 34799 238+79788 33236+1536
GC 17379 119+0 16598+0
CC 27055 185+77633 25840+1495
Total 101684 1042+216514 97183+4168
τ=τprolif+τdiff+τcorn 52.5=7.0+31.5+14.0 9.8=1.8+4.5+3.5 44.5=6.0+26.5+12.0
†Normal+Psoriatic (px + p˜x).
∗Results are generated using parameters in Table III.
dp˜sc
dt
=
[
ρscγ1,h
(
1− psc + p˜sc
λpmaxsc
)
− ρsck1s,h − β˜1
]
p˜sc
−f(p˜sc) + k˜−1p˜ta (20)
f(p˜sc) =
Kpp˜
2
sc
K2a + p˜2sc
. (21)
The psoriatic tissue activates the immune system to combat
disease cells. We assume that repertoires for normal psc
and psoriatic p˜sc stem cells are both limited by available
niche environment and psoriatic stem cells can acquire a
larger growth capacity. Parameter λ (> 1) accounts for
the fold increase in the growth capacity accessible to stem
cells. The density of normal stem cells remains limited by
pmaxsc , which is invaded by a fraction (1/λ) of psoriatic stem
cells. Equation (21) models the immune activities triggered
by psoriatic stem cells. An activated immune system induces
apoptosis of psoriatic stem cells. The activity of the immune
system (the killing rate, f(p˜sc)) is directly regulated by
the psoriatic stem cell density, under the assumption that
the immune system is activated in a faster time scale than
the tissue growth. The immune response is significantly
activated when p˜sc exceeds a threshold parameterized by
Ka and is saturated at the maximum rate Kp at p˜sc 
Ka when the psoriatic stem-cell population overwhelms that
of cytotoxic T cells. This approach hypothesizes that the
immune system combats disease stem cells, but does not
exclude the commonly-believed role by the immune system of
inducing keratinocyte overproduction, even though the model
does not explicitly couple the immune system to stem-cell
proliferation.
Proliferation rate constants γ1, k1s and k1a for the normal
stem cells are regulated by the total TA cells, pta+p˜ta, similar
to Eq. (1):
γ1
γ1,h
=
k1a
k1a,h
=
k1s
k1s,h
=
ω
1 + (ω − 1)[(pta + p˜ta)/pta,h]n .
(22)
In comparison, we assume that psoriatic stem cells are not
subject to regulation by the TA cell population and proliferate
with rates ρsc-fold higher than the homeostatic rate constants
(γ1,h, k1a,h and k1s,h) of normal stem cells. We assume
that the immune response substantially switches on when
the psoriatic stem cell population reaches 10% of stem cell
population in the normal tissue. This assumption is used to
parameterize the steepest change in the removal rate f(p˜sc)
in response to p˜sc, which sets the half-activation density at
Ka =
√
3psc,h/10. The model does not consider immune
responses against cells derived from psoriatic stem cells by
observing that reduction in stem cell population results in a
subsequent reduction in the derived keratinocyte population.
Despite its mechanistic uncertainties, psoriasis plaques
have well-defined tissue-level phenotypes, making it a good
candidate for study by a predictive model. Depending on
its severity a plaque exhibits 2-5 times increase in the total
cell density [57, 58, 69] with a relatively higher growth in the
proliferative compartment compared to the nonproliferative
compartment [60, 61]. A disordered tissue usually loses
the granular layer due to abnormal differentiation and
contains a subset of nucleated corneocytes. A psoriatic
plaque also has a turnover time several fold faster [55,
70]. More specifically, studies found in the cell kinetics of
psoriasis (i) significant increase of cell cycle marker Ki-67 in
psoriatic tissue without much change in cell cycle time [35,
71], suggesting a substantial increase in growth fraction;
(ii) transit time of keratinocytes through differentiated
compartment is shortened to 48 hrs from 240-330 hrs, 5-7
times faster than in the normal tissue [59]; (iii) transit time
through the corneum is also shortened from 14 days to 2
days [55]. These factors together result in a decrease in
the epidermis turnover time [Eq. (17)]. In addition, the
cell apoptotic index decreases nearly four fold from 0.12% to
0.035% [36], making a further contribution to keratinocytes
overproduction. Table III lists parameter values based on the
above observations, where coefficients ρta, ρtr and ρde are
fold changes over rate constants in normal kinetics of TA-cell
proliferating (γ2, k2a and k2s), transit in the nonproliferative
compartment (k3 and k4) and desquamation (α), respectively.
Like variations in normal tissues, severity and phenotype of
psoriasis vary widely across individuals and disease subtypes
and therefore for any specific condition or study the model
should be parameterized accordingly.
As the main result, the model predicts two interconverting
homeostatic modes of the psoriatic tissue (see the Appendix
for analytical details): (1) a disease state, which generates
psoriasis phenotypes of keratinocytes overproduction and
a shortened epidermal turnover time when psoriatic stem
cells outcompete normal stem cells for available niches and
overwhelm the immune system; and (2) a quiescent state,
which predicts a coexistence of a small number of psoriatic
cells with a dominant population of normal keratinocytes
when the immune system keeps the psoriatic stem cell
population low. The quiescent mode with remanent psoriatic
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FIG. 6. Psoriasis and its management by phototherapy. (a) Three dynamical phases of cell densities from psoriasis,
the UVB treatment and recovery. Trajectories are combined populations of psoriatic and normal cells. Both stochastic and
deterministic trajectories are shown. The stochastic simulation was conducted in an area of 0.1 mm−2. Inset: zoomed details
of the UVB irradiation phase (from day 1 to day 17). Psoriatic (b) and normal (c) stem cell and TA cell densities before
and after 6- or 7-episode treatment. The treatment started at time day 1. Each simulated UVB irradiation episode induces
60000-fold increases in apoptosis rate constants for stem cells and TA cells and lasts for 48 hours. The time interval between two
consecutive episodes is 56 hours (48-hr irradiation + 8-hr resting). (d) and (e) Homeostatic cell density distributions and the
epidermal turnover times for healthy, psoriatic and recovered tissues. Notice that the granular layer is missing in the psoriatic
tissue.
stem cells is a symptomless state for a psoriasis susceptible
tissue and may relapse into the disease state given favorable
conditions. On the other hand, the disease state may be
reverted back to the quiescent state by a properly designed
treatment.
The model is parameterized (Table III) to produce a
specific psoriasis phenotype, in which the total cell density
reaches 217000 mm−2 at homeostasis, more than two times
the normal epidermis (101600 mm−2), with the pathological
keratinocytes consisting of 99.5% of the total population.
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The relative growth of the proliferative compartment over
the nonproliferative compartment is about 3 vs. 2 times the
normal densities (Table IV). The epidermal turnover time is
shortened more than 5 times from 52.5 days to 9.8 days.
The psoriatic epidermis may retreat to the “quiescent”
state and achieve a remission provided that the psoriatic
stem cell density can be managed below a threshold value
(see the Appendix). Narrow-band 311 nm controlled UVB
irradiation is known as an effective treatment for managing
psoriasis [72]. For example, a recent study by Weatherhead et
al. [58] applied sequential episodes of 0.75-3 MEDs (minimal
erythemal dose) UVB irradiation to achieve plaques remission
by inducing strong apoptosis of proliferative cells. Figure 6(a)
shows a model simulation of a psoriasis remission after a
simulated sequence of 7-episode UVB irradiations. Each
UVB irradiation episode is simulated by increasing apoptosis
rate constants 60000 fold indiscriminately for normal and
psoriatic stem cells and TA cells for 48 hours followed by
a 8-hour resting interval before starting the next episode.
The entire treatment lasts 16 days. Model simulations
unveil an intriguing interplay between dynamics of psoriatic
and normal cells. Upon the initiation of irradiation, the
total cell population first declines due to the UVB-induced
apoptosis in stem cells and TA cells. Each episode of
UVB irradiation induced apoptosis in about 22% stem cells
in the pre-episode population [see Fig. 6(a) inset]. The
population of TA cells declined more substantially due to
combined effects of increased apoptosis and reduced stem-cell
symmetric and asymmetric divisions. A mild rebound
of cell densities happens in each resting interval because
of a continuing hyper-proliferation of psoriatic stem cells
and TA cells. At the end of the treatment, the total
keratinocyte density dramatically drops more than 95%
from 217000 to 12100 mm−2, with normal and psoriatic
stem cells respectively reduced to 260 and 960 mm−2.
Post-treatment stem-cell population continues to decline to
the “quiescent” steady state due to a relatively stronger
immune response [Fig.6(b) and Fig. S3(c) and related text
in the Supplementary Materials], which later brings down the
psoriatic cell density to a minimum (less than 0.5% of the
total cell density, Table IV). The granular cells become visible
during the recovery. The last phase indicates a recovery
of keratinocytes derived from the normal stem cells that
reclaim their niche repertoire by a slower kinetics [Fig. 6(c)].
The downstream differentiated cells follow similar dynamics
of remission. Simulated dynamics is similar if the model
considers UVB-induced apoptosis in all nucleated cells [results
not shown].
A treatment with less UVB irradiation episodes and/or
inadequate intensity may fail to clear a psoriatic plaque,
which eventually returns to the disease state once the
treatment stops due to an insufficient loss in psoriatic stem
cells. Figure 6(b) and (c) show that after a 6-episode UVB
irradiation treatment, the psoriatic stem cell and TA cell
populations bounce back to the disease state after terminating
the treatment. The total cell density drops to 18600 mm−2
at the end of the 6th episode with the normal and psoriatic
stem cell densities as 247 and 1263 mm−2, respectively.
Interestingly, the end-treatment normal stem-cell count is
slightly less than that from 7-episode treatment, implying
that increased normal stem cell proliferation rate due to loss
of TA cells well below the healthy level offsets the cell loss
caused by apoptosis. Shortly after the treatment stopped,
both psoriatic and normal stem cells and TA cells started slow
increases, but later the density of psoriatic cells [Fig. 6(b)]
rapidly expands and outcompetes the normal cells [Fig. 6(c)]
that retreat from a maximum to the steady state at a lower
level. During the entire course of the treatment the cytotoxic
rate remains below the growth rate of psoriatic stem cells,
giving no chance for the immune system to effectively reduce
the psoriatic stem cell population (see Fig. S3(d) in the
Supplementary Materials).
Histograms in Fig. 6(d) and (e) show that a well-designed
treatment can manage the psoriatic tissue to the quiescent
state that is almost phenotypically indistinguishable from the
healthy tissue in cell density distribution and the turnover
time. Histologically, psoriasis causes thickening in the
stratum corneum and the differentiated layer as well as an
expanded proliferating compartment with more protruding
rete ridges [73]. A dynamic model of rete ridge remodeling,
simulation snapshots of the homeostatic psoriatic epidermis,
tissue under treatment and recovered tissue can be found
in the Supplementary Material (Fig. S3-S4). Movies of
simulations (normal and psoriatic tissues) are provided at
URL: http://www.picb.ac.cn/stab/epidermal.html.
IV. DISCUSSION
We presented a hybrid model that simulates and visualizes
spatiotemporal dynamics of the epidermal homeostasis. The
model represents an efficient approach that separates the
computation of cell kinetics from that of an agent-based cell
migration. Compared to previous agent-based models [8,
9, 11, 12], our population kinetics model describes cell
proliferation, differentiation and cell death as empirical
rate processes and can be simulated by integrating the
governing ordinary differential equations (Table I) or the
master equations by a kinetic Monte Carlo algorithm. The
cell population kinetics model can be combined with a
two-dimensional cell migration model to visualize dynamics of
epidermis renewal and stratification. The model reproduces
observed characteristics of the normal epidermis. Model
analysis and simulations show that balancing cell production
and cell loss in each subcompartment is critical to establishing
and maintaining a proper epidermis homeostasis (Fig. 4).
The current model has some addressible limitations: (i)
The cell population kinetics does not explicitly incorporate
specific intracellular and extracellular factors that affect the
dynamics and steady state of the epidermis homeostasis.
However, physiological and physical factors including age
and UV irradiation as well as many commonly investigated
signaling molecules can be coarsely coupled to model
parameters such as proliferation and differentiation rate
constants and morphology of keratinocytes and the epidermis.
(ii) We neglected the effects by backconversions from TA
cells to stem cells and from differentiated cells to TA cells
by assuming their minimal impact. These processes could
be worth a close examination as suggested in a recent
theoretical study [74] that showed rare backward transitions
may cause catastrophic outcome such as a cancerous growth.
(iii) Technically, as intensive modeling and computation is
made possible by high-performance hardware [75, 76], our
two-dimensional cross-sectional model can be extended to
simulate a more realistic three-dimensional epidermis even
though we expect that the qualitative results obtained from
the 2D model remain valid in a 3D model.
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As an important application, a non-trivial extension to
the above model allows us to investigate the pathogenesis
of psoriasis, an immune-mediated skin disorder. Genetic
origins of psoriasis have been recently explored by an
increasing number of genome-wide association studies that
identified a multitude of psoriasis susceptibility loci [77–80].
Many psoriasis-associated loci are connected to genes in the
immune system (e.g., MHC class I molecules) and proteins
expressed in keratinocytes, suggesting a complex nature of
the disease [81]. However, the mechanistic epidermis-immune
system interactions implicated by these loci are yet to be
resolved.
In this study, we propose an alternative hypothesis of
interactions between the immune system and keratinocytes,
in which the disordered epidermis maintains a parallel
homeostasis of both normal and psoriatic keratinocytes,
derived from respective stem cell populations. We examine
this hypothesis in an extended model and demonstrate that
treatment by UVB irradiation with consecutive episodes can
potentially manage the disease and achieve a remission of the
psoriatic phenotype.
Psoriasis has recently been studied by agent-based
models [48, 58]. The model by Grabe and Neuber [48]
was able to generate the psoriasis phenotype of an increased
cell density and a shortened epidermal turnover time, by
adjusting the fractional time of TA cell proliferation. This
parameter characterizes the amount of time for proliferation
during a constant life time of a TA cell, which in our model
is embedded in the TA cell self-proliferation rate constant γ2.
Increasing γ2 and keeping symmetric division rate constant
k2s unchanged (equivalent to keeping a constant TA cell life
time) does increase TA cell population (Eq. 6). To obtain
a relative growth of the proliferating compartment, rate
constants for cell differentiation must have relatively higher
increases than γ2, which was achieved by modulating Ca
2+
gradient in the Grabe and Neuber model. The model however
did not propose possible management that can target the
hypothesized mechanism. For example, it is not obvious how
apoptosis induced by episodes of UVB irradiation can attain
a remission via recovering the normal TA cell proliferating
time. Weatherhead et al. [58] developed a model to simulate
UVB-induced apoptosis in stem cells and TA cells, which was
able to demonstrate a psoriasis remission after a few episodes
of UVB irradiation. The model assumed a constant pool of
stem cells that derived TA cells by asymmetric division and
the UVB-induced apoptotic hyperproliferative stem cells were
replaced with normal stem cells by symmetric divisions. This
model assumption consequently led to a permanent reduction
in cell density after each UVB irradiation treatment and
therefore did not explain relapses of psoriatic phenotypes once
an ineffective treatment ends or recurrence of the disorder.
Interactions between the immune system and keratinocytes
considered in our model can serve as a conceptual basis for
interpreting the pathogenesis of psoriasis. Especially, we
showed that the act of the immune system cytotoxicity against
psoriatic keratinocytes plays a pivotal role in the onset,
remission and recurrence of the disease phenotype. The most
common paradigm considers that faulty immune responses
triggered by unknown self antigens or pathogens (introduced
by injuries or trauma, known as Koebner phenomenon)
produce cytokines and growth factors that promote
keratinocyte hyperproliferation, immature differentiation and
skin inflammation, establishing the psoriasis phenotype.
Drugs that inhibit T cell activity and cytokine productions
do improve psoriatic conditions [82]. In contrast, our
model demonstrates that a psoriasis lesion develops when
the immune system is genuinely weakened or locally
overwhelmed by a large population of psoriatic keratinocytes,
staging up a chronic condition. This prediction may
explain high occurrence and increasing severity of psoriasis
in HIV-infected, especially late-stage AIDS patients with
substantially compromised immune systems when CD4+ and
naive CD8+ T cell counts substantially decrease [83, 84].
Furthermore, the onset age of psoriasis has been known to
have two separate populations, type I (early onset in patients
younger than 40 with a peak at age 20) and type II (late
onset after age 40 with a peak at about 60) [85]. Our
model speculates that a vigorous immune system at a younger
age can stimulate a strong hyperproliferation (a large ρsc)
in a psoriatic epidermis and causes manifestation of plaque
phenotypes. One the other hand, a weak immune system (a
small kp) at an older age can also have an equivalent effect.
The model prediction provides an alternative (a less
explained) perspective of the pathogenesis of psoriasis,
suggesting that psoriasis is a parallel epidermal homeostasis
due to heterogeneity in stem cell clones, and that the immune
system as a double-edged sword plays two essential however
opposing roles: (i) Cytotoxic (CD8+) T cells recruited to
the epidermis induce apoptosis in psoriatic stem cells, which
is implicated by studies that demonstrated CD8+ T cell
(especially, CD45RO+ memory subtype) count and cytotoxic
proteins including perforin and granyme B substantially
increase in psoriatic lesions [83]; and (ii) Immune activities in
the meantime promote progenitor keratinocytes proliferation
by producing a multitude of cytokines and growth factors
(TNF, IFN-α, IFN-γ, IL-17, IL-22, IL-23, etc.). Balance
between the two acts determines the outcome of the disease.
Our model predicts that the psoriasis-susceptible tissue is a
bimodal system and can switch between a non-symptom state
and a phenotypical state, potentially explaining the recurring
nature of the disorder and suggesting the feasibility of disease
management by an effective treatment. This perspective and
the model could be in general applicable to other autoimmune
diseases in regenerative tissues.
We showed in UVB phototherapy simulation that psoriasis
plaque clearance can be attained by inducing strong apoptosis
in keratinocytes. The model only considered UVB-induced
apoptosis in keratinocytes. UVB irradiation may promote
proliferation and differentiation in skin cells [86, 87] or may
alter immune responses. These effects could be incorporated
and be examined in the model. For example, as suggested
in Eq. (20), rebalance in self-proliferation γ1,h and symmetric
division k1s,h and change in immune activities f(p˜sc) may
affect the population of psoriatic stem cells and thus the
therapeutic outcome. Experiments did not demonstrate
whether the UVB irradiation causes non-apoptotic cell death
that was not reflected by an apoptosis marker [58]. Regardless
the actual mechanism, induced cell deaths will result in a shift
of the stem cell density from the disease state to the quiescent
state across the phase boundary, an important parameter that
determines the design of a phototherapy regimen, including
irradiation dosage in each treatment episode, the number of
episodes and the time interval between consecutive episodes.
The model also suggests the limitation of UVB
irradiation or similar treatments that attempt to achieve
plaque remission by killing keratinocytes below a critical
threshold. First, psoriasis plaques may recur under a
temporally-weakened immune system or a transient burst of
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cell proliferation caused by conditions such as wound healing.
Second, the psoriatic severity may be worsened under a
genuinely weak immune system (with a low Kp and/or a
high threshold Ka), in which the disease phenotype persists
and cannot be adequately reverted by simple reduction in
psoriatic stem cells because the system does not possess a
quiescent state [region I in Fig. 7(b)]. In the latter case,
other treatment options such as cytokine-targeting biologic
and small-molecule drugs should be considered to at least
shift the disorder to the bimodal region where phototherapy
becomes effective. However, we note that phototherapy may
be effective through alternatively mechanisms other than
induction of apoptosis [88, 89], by which it alone may switch a
plaque from persistent disorder (region I) to bimodal (region
II) or symptomless (region III) as in Fig. 7(b).
Further insight from the model is that the bimodal psoriasis
exhibits hysteresis, by which a mode of the epidermis,
psoriatic or quiescent, once reached under a favorable
condition, will tend to be relatively stable. For example,
a symptomless epidermis as illustrated in Fig. 7(b) may
switch to the disease state when Kp is reduced beyond its
lower threshold because of weakening in the immune system.
However, restrengthening the immune system to revert the
disease state back to the quiescent mode requires elevating Kp
in the model beyond the upper threshold, implying that the
disease is resistant to mild natural or induced perturbations.
One definitive experimental test of our model hypothesis
should aim at simultaneously tracing clones of psoriatic and
normal stem cell lineages. Because of recent advancement in
techniques, studies of epidermal stem cells become central to
the understanding of the epidermal homeostasis. Especially,
the emerging powerful in vivo lineage tracing technology
allows dynamic monitoring of stem cells and progenitors
clone formation and differentiation and can achieve multicolor
simultaneous tracing of separate clones [27]. The technique
has already been pioneered to study progenitor fates in normal
skin tissue [17] and benign epidermal tumors [90] and can be
potentially applicable to identify the coexistence of normal
and psoriatic progenitors in psoriasis. One potential challenge
is that in either quiescent or disease state one type of stem
cells is in a small population (about a 1:20 ratio, according
to Table IV), making it difficult for differential labeling.
Alternatively, an experiment may tend to identify and isolate
the two competing effects by the immune system on the
epidermis: (1) apoptosis in epidermal progenitors by T-cell
cytotoxic activities and (2) hyperproliferation due to elevated
cytokines and growth factors.
Appendix A: Analytical details of the psoriasis
model
Psoriasis as a bimodal switch — To illustrate the principle
and simplify the analysis, we only present a two-dimensional
model that describes dynamic interactions between normal
and psoriatic stem cells. The complete model that produced
the results (Fig.6) is more complex and of a higher dimension
because of the feedback regulation by TA cell population
on the normal stem cell proliferation (Eq. 22), requiring
analyzing the dynamics of normal and psoriatic TA cells
together. Again, for convenience in analysis, we neglect
the influences of backconversions and apoptosis. This
simplification allows us to show insights of the model
behaviors without much mathematical complication. We
work with normalized quantities:
x = p˜sc/Ka, y = psc/Ka, y
max = pmaxsc /Ka, kp = Kp/Ka .
Ratios between the normal stem-cell proliferation rate
constants remain constant despite their dynamic modulations
by the TA cell population (Eq. 1), i.e., k1s/γ1 = k1s,h/γ1,h.
Ignoring the trivial steady states of zero density (x = 0,
and/or y = 0), based on Eqs. (19-21) we have the steady-state
equations for stem cell densities as
w
(
1− x
u
)
− x
1 + x2
= 0 , (A1)
y =
u− x
λ
, (A2)
where
w =
ρsc
kp
(1− 1/λ)(γ1,h − k1s,h) ,
u = λymax(1− k1s,h/γ1,h) .
Eq. (A1) can solve for one or three steady-state psoriatic stem
cell densities, only depending on choices of two parameters,
w and u, which is illustrated in Fig. 7(a).
To study plaque remission and relapse, we are interested in
the region where the system has two stable steady states,
“quiescent” and “disease”, and one unstable “transition”
steady state. This scenario is illustrated in Fig. 7(a) with
three intersections between the line w(1 − x/u) and the
nonparametric curve x/(1 + x2). Determination of the
stability of these fixed points requires analysis similar to the
spruce budworm model by Ludwig et al. [68]. Figure 7(a)
shows that the “quiescent” state is more sensitive to w,
whereas the “disease” state is determined by both u and
w. This observation provides a guideline to parameterize
the model to attain appropriate psoriatic phenotypes by
identifying disease-related parameters ρsc, λ and kp. The
ratio ρsc/kp emerges as the key parameter that characterizes
the interplay between proliferation of keratinocytes and
activity of the immune system (magnitude Kp and threshold
Ka), playing a critical role in the interpretation of the
pathogenesis of psoriasis.
Bifurcation diagrams in Fig. 7(b) of steady-state stem
cell densities shows three classes of behaviors as ρsc/kp
varies. A small population of psoriatic stem cells survive
in the “quiescent” state (ρsc/kp <159 day) under a vigorous
cytotoxic activity (a large kp, i.e., a low threshold Ka and/or a
high magnitudeKp) and/or a moderate stem-cell proliferation
(a small ρsc). In contrast, a weak immune system (a small kp,
i.e., a high threshold Ka and/or a low magnitude Kp) cannot
adequately counterbalance the psoriatic hyperproliferation
(a large ρsc) and thus the epidermis assumes a persistent
“disease” state (ρsc/kp >440 day). A bimodal system with
an intermediate ρsc/kp has a potential to switch between
the quiescent and disease modes when conditions change.
Figure 7(c) shows a two-dimensional phase plane of normal
and psoriatic stem-cell densities. Starting from initial stem
cell densities, located inside region I or II, a temporal
trajectory will be attracted to the quiescent or the disease
state, respectively. Those starting on the boundary of the two
regions will in theory converge to the transition state, which
is unsustainable because slight perturbations will dislocate a
trajectory into either region I or II.
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FIG. 7. Steady states of the psoriasis model. (a)
Intersections of the two functions give the steady states
(Eq. A1) and can be modulated with w by changing Kp within
the range of two bifurcation points (indicated by dashed
lines). The “quiescent” and “disease” states (filled circles)
are stable steady states. The “transition” state (empty circle)
is unstable (i.e., arbitrarily small perturbations deviate the
system away from it). (b) Bifurcation diagram under varying
ration ρsc/kp with three regions: (I) persistent disorder,
(II) bimodal, and (III) symptomless. (c) Trajectories from
basins of attraction: I and II, separated by the boundary
(dashed line), converging to the quiescent and disease states,
respectively. Blue and red curves are nullclines (Eqs. A1 and
A2). Parameter values used for the simulation are listed in
Table III.
Cell density and turnover time — Below, we provide
equations for homeostatic cell densities and the turnover time
in the psoriatic model. As shorthands, we define
g =
k1a + 2k1s
k2s − γ2 , gh =
k1a,h + 2k1s,h
k2s − γ2 ,
The ratio ξ = g/gh is a function of the steady-state TA cell
population (pta+ p˜ta) by Eq. (22). The total steady-state cell
density is given as
ptot = psc (1 + ξghW ) + p˜sc
(
1 +
ρsc
ρta
ghW˜
)
,
where
W = 1 + (k2a + 2k2s)
(
1
k3
+
1
k4
+
1
k5
+
1
α
)
,
W˜ = 1 + (k2a + 2k2s)
(
1
ρtrk3
+
1
ρtrk4
+
1
ρdeα
)
ρta .
Notice the lack of GC layer in the psoriatic cell population.
The proliferative and differentiated cell populations are
pprolif = psc(1 + ξgh) +
(
1 +
ρsc
ρta
gh
)
p˜sc
pdiff = gh(k2a + 2k2s)
(
pscξ +
ρsc
ρtr
p˜sc
)(
1
k3
+
1
k4
)
+pscξgn
k2a + 2k2s
k5
.
Corneocytes are not included in the differentiated
compartment. By comparison, the cell densities in the
healthy tissue are
pprolif,h = psc,h(1 + gh) ,
pdiff,h = gh(k2a + 2k2s)psc,h
(
1
k3
+
1
k4
+
1
k5
)
.
We can calculate the growth of the proliferative compartment
relative to that of the nonproliferative compartment as
pprolif/pprolif,h
pdiff/pdiff,h
=
psc(1 + ξgh) +
(
1 + ρsc
ρta
gh
)
p˜sc
(1 + gh)
×
1
k3
+ 1
k4
+ 1
k5(
pscξ +
ρsc
ρtr
p˜sc
)(
1
k3
+ 1
k4
)
+ pscξ
1
k5
>
psc(1 + ξgh) +
(
1 + ρsc
ρta
gh
)
p˜sc
(1 + gh)
(
pscξ +
ρsc
ρtr
p˜sc
) .
A relative increase in the proliferative population requires the
above ratio to be greater than 1. In psoriasis, ξ < 1, reflecting
a decreased proliferation rate in the cohabitating normal stem
cell population due to a much elevated TA cell population. It
is unclear whether stem cells and TA cells have differential
increases in proliferation rates. For the lack of information,
we assume ρsc/ρta ≈ 1. Therefore, ρtr > ρsc becomes a
sufficient (but not a necessary) condition to produce a relative
increase in the proliferative compartment, requiring that the
fold increase of transit rate in the differentiated compartment
is higher than the fold increase of division rates in the
proliferative compartment. This result agrees with an earlier
prediction from Heenen et al. [60], showing that a relative
growth in the proliferative compartment requires keratinocyte
hyperproliferation and in the meantime an increased transit
time in the differentiated compartment. A proportional
increase in both TA-cell proliferation rate and transit rate
(ρsc = ρtr) does not cause relatively differential growth
of the two compartments unless difference exists between
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increases of proliferating rates of stem cells and TA cells,
ρsc 6= ρta. Fast migration of differentiated keratinocytes
also offsets overgrowth in the proliferative compartment.
An important insight from the model is that increasing
keratinocyte population in psoriasis is not merely caused
by elevated proliferation rates but also requires the increase
in growth capacity in the progenitor repertoire. Observed
morphological remodeling of the psoriatic epidermis suggests
increased growth niches for stem cells [73].
Similarly to Eq. (17), the epidermal turnover time can be
approximated as the ratio of the total cell density to the rate
of desquamation:
τ˜tot ≈ ptot
α(pcc + ρdep˜cc)
=
(
psc + p˜sc
pscξ + ρscp˜sc
1
gh
+
pscξ +
ρsc
ρta
p˜sc
pscξ + ρscp˜sc
)
1
k2a + 2k2s
+
pscξ +
ρsc
ρtr
p˜sc
pscξ + ρscp˜sc
(
1
k3
+
1
k4
)
+
pscξ
pscξ + p˜scρsc
1
k5
+
pscξ +
ρsc
ρde
p˜sc
pscξ + ρscp˜sc
1
α
,
which can be analyzed for the two psoriasis modes (quiescent
or disease). At the quiescent mode, ξ ≈ 1 and psc  p˜sc, the
turnover time is approximated by
τ˜tot ≈
(
k2s − γ2
k1a + 2k1s
+ 1
)
1
k2a + 2k2s
+
1
k3
+
1
k4
+
1
k5
+
1
α
,
converging back to τtot. At the disease mode, ξ < 1 and
psc  p˜sc. The turnover time is close to:
τ˜tot ≈
(
1
ρscgh
+
1
ρta
)
1
k2a + 2k2s
+
1
ρtr
(
1
k3
+
1
k4
)
+
1
ρde
1
α
.
Both cases do not account for the relatively much smaller
cell loss by the cytotoxic effect from the immune system.
Compared to the turnover time of the healthy tissue τtot
(Eq. 17), τ˜tot of the psoriatic tissue is clearly shortened
at each stage from the proliferative compartment (the first
term) to differentiated compartment (the second term) and
to the corneum (the third term). The turnover time of the
granular layer is ignorable because of the minimal normal cell
population.
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SUPPLEMENTARY MATERIALS
Computation of population kinetics model
The central transition pathway of the epidermis renewal
can be computed in two alternative ways (Fig. S1) to obtain
the deterministic or stochastic dynamics of the system. The
mathematical equations [the ordinary differential equations
(ODEs) or the master equations] of the system for the normal
tissue can be found in Table 1 of the paper.
Deterministic simulation — The deterministic model
describes cell populations by a set of ODEs with the cell
densities as the state variables according to the rate processes
in the central transition pathway. Numerically integrating the
ODEs obtains trajectories of the cell density distribution over
all individual cell types.
Stochastic simulation — In this case, rate processes in the
central transition pathway are sampled by the Gillespie’s
algorithm [1] to generate probabilistic cellular events
sequentially in time. An individual cell process is chosen
by a probability proportional to the rate of the process, and
the occurrence time interval is sampled as in a Poissonian
process with a mean rate equal to the accumulated rate of all
processes in the system. Time series of cell events generated
by the stochastic simulation are fed to the agent-based cell
migration model to simulate and visualize the spatiotemporal
organization of keratinocytes in the epidermis.
Computation of agent-based cell migration model
Simulation of the cell migration model is coupled with
the stochastic simulation of the cell population kinetics
model described in the previous section. Because the
cell population kinetics is treated independently from the
cell migration in our model, the stochastic simulation of
population dynamics can be completed before simulating
the cell migration, and the generated cellular events of
proliferation, differentiation, apoptosis and desquamation
can be stored and later embedded into the time series of
migration events.
Repulsive force — The amount of repulsive force Frij is
assumed to be proportional to the overlapping area Sij and
the direction of the force is along the line connecting the
cell centers of cells i and j. At time t, the two orthogonal
components Frij(t) ≡ [F r,xij (t) , F r,yij (t)] is given as
F r,xij (t) = kSij(t) cos θij , and F
r,y
ij (t) = kSij(t) sin θij , (S1)
where θij is the angle of vector F
r
ij and k is a constant assumed
identical for all cell types.
In theory, the overlapping area between two ellipsoids can
be precisely calculated by a numerical integration. To increase
computational efficiency, Sij (note that Sij = Sji) is however
approximated by the overlap between the two cells as if
they are rectangles with widths and heights identical to the
corresponding ellipsoids. An overlap happens between cells i
and j if the following two conditions hold:
|xi − xj | < wi + wj
2
, and |yi − yj | < hi + hj
2
, (S2)
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FIG. S1. Schemes of model computation. Kinetics
of the central transition pathway of the epidermis renewal
can be computed by one of the two numerical methods: (i)
integrating the system of ODEs, or (ii) stochastic simulation
algorithm (SSA). As a third option (iii), the spatio-temporal
dynamics of the epidermis renewal can be computed and
visualized by incorporating cell events generated by the
stochastic simulation into the cell migration model.
where hi and wi are height and width of cell i, respectively.
The width and height, wij and hij , of the overlap rectangle
can then be calculated as
wij = min{wi + wj
2
− |xi − xj |, wi, wj} (S3)
hij = min{hi + hj
2
− |yi − yj |, hi, hj} , (S4)
and the overlap area is approximated as Sij ≈ wijhij .
Adhesive force — We adapt the treatment of cell-cell adhesive
force from Palsson model [2] and Li et al. [3]. The adhesive
force between two adjacent cells i and j, Faij , is a biphasic
function of the cell-cell distance and the direction of the
force is along with the line connecting the cell centers. We
have the following equation for Faij (see Fig. S2 for plots of
force-distance relationship):
F aij = −σ
[(gij
r
+ c1
)
e−ζ(
gij
r
+c1)
2 − c2e−ζ(
gij
r
)2
]
, (S5)
where c1 = 1/
√
2ζ, c2 = c1e
−1/2, r is the average radius
of cells, gij is the distance between cell i and cell j. The
adhesion factor σ is a measure of the strength of the adhesion.
0 0.3r r 2r0
0.025
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gik
F
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a
/
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ζ=14
FIG. S2. Adhesive force. The normalized adhesive force
(F aik/σ) related the cell-cell distance under different ζ values.
The adhesive force decreases to zero at ζ = 7 when the cell-cell
distance exceeds the cell radius r.
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FIG. S3. Psoriasis phototherapy by multi-episode UVB irradiation. (a) 7-episode and (b) 6-episode UVB irradiation
treatments. The model simulated an area of length 5 mm × width 0.01 mm =0.05 mm2 (i.e., a single-cell sheet of the
epidermis). Simulations started with a mixed population of normal (solid) and psoriatic (dashed) stem cells (about a 20:200
ratio). Temporal evolution of the cytotoxic killing rate and psoriatic stem cell (PSC) net proliferation rate (selfproliferation
rate - symmetric division rate) in (c) 7-episode and (d) 6-episode UVB irradiation. Note that compared to (a) and (b), time
axes are shifted in plots (c) and (d) to remove the initial transient dynamics to psoriatic homeostasis. The UVB treatments
follow the same protocol described in the main text (Fig. 6). Parameter values used in the simulations are listed in the main
text (Table 3).
The density of desmosomes (typical cell junctions) has a
nonuniform distribution across different layers indicating
varying adhesion strength in different cell types [3–5]. σ can
be adjusted for different keratinocytes to reflect this variation.
We assume that the adhesion strength in proliferating cells
is the strongest and decreases from inner to outer layer
in non-proliferating compartment due to decreased density
of desmosomes. For example, the corneocytes has reduced
adhesion as Skerrow et al. [4] reported that the ratio of
desmosome densities of differentiated layers and corneocyte
layer was about 6. For calculating the adhesion forces between
different cell types a and b, the mean σab = (σa+σb)/2 is used.
We also note that stem cells are located on niches and move
laterally along the basement membrane.
Parameter ζ is usually assumed to be 7 with which the
adhesive force is almost zero when the distance between two
cells is larger than the mean cell radius r. The force increases
as the distance increases from zero and reaches a max force
when the distance is about 0.3r (see Fig. S2). As the
distance increases further, the adhesion declines to zero. For
computational efficiency, the distance between two adjacent
cells is approximated by the shortest distance between cells
represented as rectangles with widths and heights identical
to the corresponding ellipsoids. The cell-cell distance is
calculated by
gij =
√
x2ij + y
2
ij . (S6)
where
xij = max{|xi − xj | − wi
2
− wj
2
, 0} (S7)
yij = max{|yi − yj | − hi
2
− hj
2
, 0} (S8)
The equation of motion for cell migration
µ
dxi
dt
+ Fri + F
a
i = 0 , (S9)
Fri =
∑
j=O(i)
Frij , F
a
i =
∑
j=Ω(i)
Faij (S10)
can be numerically solved for individual cells by a finite
difference method. With a small time step ∆tc, given the
location of cell i at time t, xi(t), one can estimate the cell
location xi(t+ ∆tc) as a first-order approximation,
xi(t+ ∆tc) ≈ xi(t)− F
r
i (t) + F
a
i (t)
µ
∆tc . (S11)
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TABLE V. Operation rules for cell events in the cell migration model
Event Operation rule
SC→ SC + TA Randomly divide a SC and place daughter cells beside each other†
SC→ SC + SC Randomly divide a SC and place daughter cells beside each other†
SC→ TA + TA Randomly divide a SC and place daughter cells beside each other†
TA→ SC Randomly replace a (normal) TA cell or replace the lowest (psoriatic) TA cell by a SC†
TA→ TA + TA Randomly divide a TA cell and place daughter cells beside each other
TA→ GA + TA Randomly divide a TA cell at the boundary and place daughter cells beside each other
TA→ GA + GA Divide the outmost TA cell and place daughter cells beside each other
GA→ TA Randomly replace a GA cell at the boundary by a TA
Differentiation Replace the outmost cell by a cell of the new type
Apoptosis Randomly choose a cell of proper type and remove
Desquamation Remove the outmost CC
†SCs and normal TA cells only undergo lateral motion along the basement membrane.
The basement membrane — Cell migration is bounded by
the basement membrane, whose morphology and remodeling
must be accounted for. The undulant basement membrane at
location x, is generated by a shifted Gaussian function:
−H(x) = Ae−(x−x0)2/σ2s −B , (S12)
where parameters A, B and σs model the depth and width
of the rete ridge. The variable x0 controls the location of
a rete ridge along the basement membrane. Simulations
introduce 10% fluctuations in parameters A and σs and in
cell sizes (width and height) about the means when a new (or
newly differentiated) cell is produced. Periodical boundary
condition was used to process cell motion across the left
and right boundaries. In the normal tissue, proliferating
cells including stem cells and TA cells only undergo lateral
movement along the basement membrane.
The complete algorithm that simulates the stochastic
spatiotemporal dynamics of the epidermis renewal is outlined
as follows.
1. Simulate the cell population kinetics model with the
Gillespie’s algorithm, and store the time series of cell
events.
2. Specify the basement membrane and coordinates of the
initial cell population and calculate mechanical forces
exerted on each individual cells using Eqs. (S1), (S5)
and (S10), and set the simulation time t = 0 and the
time step ∆tc.
3. Execute available cell events within [t, t+∆tc] according
to the rules described in Table V.
4. Calculate mechanical forces for all affected cells and
migrate cells to the new coordinates calculated by
Eq. (S11), and advance the time t← t+ ∆tc.
5. Iterate Step 3 until stop.
The model simulation and visualization algorithms are
implemented in the Matlab and Java Language and are
available at http://www.picb.ac.cn/stab/epidermal.html.
Simulations of psoriatic epidermal homeostasis and
treatment by UVB irradiation
Both deterministic and stochastic dynamics of a psoriasis
plaque and its post-treatment remission after 7-episode UVB
irradiations and relapse after 6-episode UVB irradiation are
shown in Fig. S3(a) and (b). The dynamic interplays
between the cytotoxic effect by the immune system and the
psoriatic stem cell proliferation are shown in Fig. S3(c) and
(d) for the 7-episode (effective) and 6-episode (ineffective)
treatments, respectively. At the pretreatment homeostasis,
the cytotoxic effect on PSC (the killing rate) balances the
net PSC proliferation rate. Upon the start of a UVB
irradiation, the PSC net proliferation initially increases
due to increased self-proliferation that tends to fill the SC
niche capacity, but however drops back during later UVB
episodes because the healthy SCs proliferation picks up the
competition for the niches. In this phase, the cytotoxic
rate gradually drifts lower because of the reduced PSC
population. A successful treatment (7-episode in Fig S3(c))
brings the net PSC proliferation below the cytotoxicity at
the end of the therapy and from there the plaque eventually
achieves a remission where two rates balance again at the
quiescient mode homeostasis. By contrast, in a less-dosed
regimen (6-episode in Fig S3(d)), the net PSC proliferation
stays higher than the cytotoxicity throughout. Once the
treatment stops, PSC proliferation progressively outcompetes
and healthy SC proliferation for the niches and the plaque
relapes in the end.
Fig. S4 shows a few snapshots of 2D tissue stratification
during a simulation. Simulation movies are available at URL:
http://www.picb.ac.cn/stab/epidermal.html.
In the psoriatic tissue, because of high density of
proliferating cells, TA cells are allowed to migrate within a
larger (but restricted) area, within a band parallel to the
basement membrane. The height of the band is modulated
by the density of proliferating cells with a 15 µm increment
(decrement) for every 18000 mm−2 increase (decrease) in
proliferating cell density.
In comparison to a fixed rete ridge, the dynamics of rete
ridge remodeling is considered in the psoriasis model. We
assume that the rete ridge remodels between normal and
psoriatic structures according to proportions of normal and
psoriatic cells. The fraction of normal progenitor cells is
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defined as
r =
normal SC + TA cells
total SC + TA cells
, (S13)
Let y be the rete ridge height in time and Y is the target
homeostatic rete ridge height. We assume that the dynamics
of the rete ridge follows a first-order dynamics
τ
dy
dt
= Y − y , (S14)
where τ is the time constant for the dynamics. We further
assume Y is linearly regulated by r:
Y = Ymax − (Ymax − Ymin)r , (S15)
where Ymax (Ymin) is reached at r = 0 (r = 1).
Eq. (S14) is numerically solved by the finite difference
method as follows:
y(t+ ∆tbm) =
Y (t)− y(t)
τ
∆tbm + y(t), (S16)
where Y (t) is calculated from Eq. (S15).
We set Ymin =40 µm to match the healthy tissue when
normal stem cells dominate at the homestasis and Ymax =126
µm, about 3 times higher than the normal epidermis.
Based on data from successful UVB treatments showing that
psoriasis plaques achieved remission in about 3-4 months [6–
8], we set the time constant τ =100 day and ∆tbm was chosen
as 20 day. In a simulation, whenever the basement membrane
remodels, all stem cells and normal TA cells are relocated
along with the membrane accordingly and other cells stay
above the basement membrane.
Identification of model parameters
We archive parameter values in Table 2 and 3 in the
main text. The literature that reported parameter values
or provided information to derive the parameter values is
listed in the tables. For example, cell sizes of keratinocytes at
different stages are reported in histology studies, and rate
constants for proliferation and differentiation are assigned
based on measurements (such as the stem cell proliferation
rate) or identified from cell density distribution data and
the measured epidermal turnover time. We list multiple
references for a parameter value if available for confirmation,
but we acknowledge that the reference list may not be
exhaustive. We also note that these parameter values serve
as references and should not be considered as fixed because
of variations of the epidermis homeostasis at skin location,
age, gender and pathological conditions and uncertainties in
experimental measurements.
Parameters that are not measured are estimated or
assumed (as indicated in the Tables). Assumed parameter
values are justifiable based on available information. For
example, the stem cell growth capacity pmaxsc in the healthy
tissue is assumed as 4.5e3 mm2, about 2 times the homeostatic
density, considering significant loss of stem cells through
symmetric division and apoptosis. In comparison, the growth
capacity in the psoriatic tissue is extended (λ = 3.5 fold
larger), which was suggested by the histology data that
showed extending rete ridge. Correspondingly, the maximum
rete ridge height Ymax is assumed more than 3 times that of
the healthy one. Parameters such as the maximum cytotoxic
rate Kp have not been experimentally measured, which is
chosen to predict a psoriasis mode (e.g., Kp = 6 mm
−2day−1
is chosen to parameterize a switchable psoriatic tissue).
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FIG. S4. Snapshots of simulated psoriatic epidermis under a 7-episode UVB irradiation (visualization of
simulation in Fig. S3(a)). Each snapshot shows two fifth of the simulated length of 5 mm. Same types of normal
and psoriatic cells are identically colored but with different contrasts as annotated in the top panel. The simulation starts
at day 1 with a mixed initial population of normal (20) and psoriatic (200) stem cells randomly distributed on the basement
membrane. The simulated tissue grows through a transient phase (Day 41, a mix of normal and psoriatic cells are visible. Note
that in this phase the disparity in growth rates of normal and psoriatic keratinocytes generate morphological heterogeneity in
the epidermis.) to achieve a parallel homeostasis between normal and psoriatic keratinocytes (Day 1040, most cells are psoriatic
and the epidermis thickens with extended rete ridges). Episodes of UVB irradiation reduce the cell population (Day 3057, at
the early recovery with normal cells). After recovery, the epidermis is composed primarily of normal keratinocytes (Day 3635).
In simulation, the rete ridge in psoriasis is dynamically extended (see the text for the dynamic model of rete ridge) to reach
a height of 126 µm at the homeostasis (about 3-4 times larger than that of the normal tissue [9, 10]). The simulation sets a
small ∆tc = 0.002 day to ensure accurate numerical integration and to bracket within each migration time step only a few
(about 2) cellular events happen along a unit epidermal length (1 mm). Psoriatic TA cells are not anchored but migrate within
a confined region above the basement membrane with a height depending on the TA cell density.
